申请人:Universite de Montreal
公开号:US05580867A1
公开(公告)日:1996-12-03
Myocardial protection is achieved by administering to a patient an effective amount of a benzothiazepine derivative. The benzothiazepine derivatives have the following general chemical formula: ##STR1## wherein R.sub.1 represents hydrogen or methyl, R.sub.2 represents hydrogen or acetyl, R.sub.3 represents hydrogen or methyl, and R.sub.4 represents hydrogen or a halogen, with the proviso that R.sub.1 cannot be methyl when R.sub.2 =acetyl, R.sub.3 =methyl and R.sub.4 =hydrogen. The above compounds may also be used in other clinical conditions such as treatment of stable and unstable angina, non-Q-wave myocardial infarction, cerebral trauma ischemia and reperfusion, organ graft preservation, etc.
心肌保护是通过向患者施用有效量的苯并噻吩衍生物实现的。苯并噻吩衍生物具有以下一般化学式:##STR1##其中R.sub.1代表氢或甲基,R.sub.2代表氢或乙酰基,R.sub.3代表氢或甲基,R.sub.4代表氢或卤素,但有一项限制,即当R.sub.2 =乙酰基,R.sub.3 =甲基且R.sub.4 =氢时,R.sub.1不能为甲基。上述化合物还可以用于其他临床情况,如稳定性和不稳定性心绞痛、非Q波心肌梗死、脑外伤缺血和再灌注、器官移植保存等。